Posttherapy [¹⁸F] fluorodeoxyglucose positron emission tomography in carcinoma of the cervix: Response and outcome

Keyphrases

• 18F-fluorodeoxyglucose (18F-FDG) 20%
• 18F-fluorodeoxyglucose Positron Emission Tomography (18F-FDG PET) 100%
• Anatomic Site 20%
• Cause-specific Survival 40%
• Cervical Cancer 40%
• Cervical Carcinoma 100%
• Cervix 20%
• Cox Proportional Hazards Model 20%
• External Irradiation 20%
• Fluorodeoxyglucose 20%
• Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) 20%
• Fluorodeoxyglucose Uptake 100%
• Imaging Scan 20%
• Intracavitary Brachytherapy 20%
• Lymph Node 20%
• Metastatic Disease 20%
• Molecular Imaging 20%
• P Factor 20%
• Patient Outcomes 20%
• Positron Emission Tomography 60%
• Prognostic Factors 40%
• Response to Therapy 20%
• Retrospective Medical Record Review 20%
• Survival Estimation 40%
• Survival Outcomes 20%
• Treatment Completion 20%
• Treatment-related 20%
• Tumor Recurrence 20%
• Tumor Response 20%
• Weekly Cisplatin 20%
• Whole-body 60%

Medicine and Dentistry

• Carcinoma 100%
• Cause Specific Survival 28%
• Cervical Cancer 28%
• Cervix 100%
• Cisplatin 14%
• Fluorodeoxyglucose 100%
• Fluorodeoxyglucose F 18 100%
• Intracavitary Brachytherapy 14%
• Lymph Node 14%
• Medical Record 14%
• Metastatic Carcinoma 14%
• Molecular Imaging 14%
• Neoplasm 14%
• Positron Emission Tomography 100%
• Prognostic Factor 28%
• Proportional Hazards Model 14%
• Survival Estimate 28%
• Tumor Recurrence 14%
• Whole Body PET 28%